Neuropathogenesis-on-chips for neurodegenerative diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amartumur, Sarnai | - |
dc.contributor.author | Nguyen, Huong | - |
dc.contributor.author | Huynh, Thuy | - |
dc.contributor.author | Testaverde S. Kim | - |
dc.contributor.author | Woo, Ran-Sook | - |
dc.contributor.author | Oh, Eungseok | - |
dc.contributor.author | Kim, Kyeong Kyu | - |
dc.contributor.author | Lee, Luke P. | - |
dc.contributor.author | Chaejeong Heo | - |
dc.date.accessioned | 2024-05-28T06:50:02Z | - |
dc.date.available | 2024-05-28T06:50:02Z | - |
dc.date.created | 2024-03-25 | - |
dc.date.issued | 2024-03 | - |
dc.identifier.issn | 2041-1723 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/15197 | - |
dc.description.abstract | Developing diagnostics and treatments for neurodegenerative diseases (NDs) is challenging due to multifactorial pathogenesis that progresses gradually. Advanced in vitro systems that recapitulate patient-like pathophysiology are emerging as alternatives to conventional animal-based models. In this review, we explore the interconnected pathogenic features of different types of ND, discuss the general strategy to modelling NDs using a microfluidic chip, and introduce the organoid-on-a-chip as the next advanced relevant model. Lastly, we overview how these models are being applied in academic and industrial drug development. The integration of microfluidic chips, stem cells, and biotechnological devices promises to provide valuable insights for biomedical research and developing diagnostic and therapeutic solutions for NDs. © The Author(s) 2024. | - |
dc.language | 영어 | - |
dc.publisher | Nature Research | - |
dc.title | Neuropathogenesis-on-chips for neurodegenerative diseases | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 001185523200019 | - |
dc.identifier.scopusid | 2-s2.0-85187721815 | - |
dc.identifier.rimsid | 82780 | - |
dc.contributor.affiliatedAuthor | Testaverde S. Kim | - |
dc.contributor.affiliatedAuthor | Chaejeong Heo | - |
dc.identifier.doi | 10.1038/s41467-024-46554-8 | - |
dc.identifier.bibliographicCitation | Nature Communications, v.15, no.1 | - |
dc.relation.isPartOf | Nature Communications | - |
dc.citation.title | Nature Communications | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | PLURIPOTENT STEM-CELLS | - |
dc.subject.keywordPlus | PRION-LIKE PROPAGATION | - |
dc.subject.keywordPlus | SELECTIVE NEURONAL VULNERABILITY | - |
dc.subject.keywordPlus | AMYOTROPHIC-LATERAL-SCLEROSIS | - |
dc.subject.keywordPlus | HUMAN BRAIN ORGANOIDS | - |
dc.subject.keywordPlus | CAG REPEAT LENGTH | - |
dc.subject.keywordPlus | ALPHA-SYNUCLEIN OLIGOMERS | - |
dc.subject.keywordPlus | AMYLOID PRECURSOR PROTEIN | - |
dc.subject.keywordPlus | A-BETA TOXICITY | - |
dc.subject.keywordPlus | HUNTINGTONS-DISEASE | - |